HIGHLIGHTS
- who: Anneke Corinne Dijkmans et al. from the Centre for Human Drug Research, Leiden, CL, The NetherlandsDepartment of Medical Microbiology, Radboud University Medical Center have published the article: Fosfomycin: Pharmacological, Clinical and Future Perspectives, in the Journal: (JOURNAL)
- future: Studies are urgently needed to assess the PK safety tolerability and efficacy of fosfomycin in both multiple-dose regimens and synergistic combinations. Because essential pharmacological information and knowledge regarding mechanisms of resistance are currently limited and/or controversial further studies are urgently needed and fosfomycin monotherapy should be avoided.
SUMMARY
Because it . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.